Accolade, Inc. (ACCD)
After hours:
- Zacks
Accolade (ACCD) Expected to Beat Earnings Estimates: Should You Buy?
Accolade (ACCD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- GlobeNewswire
Accolade to Announce Fiscal Second Quarter 2023 Financial Results
SEATTLE, Sept. 19, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves over 600 employers and millions of members, today announced that it will release fiscal second quarter 2023 financial results on Thursday, October 6, 2022, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call Details To Listen via Telephone: Pre-registration is required by the conference call
- Simply Wall St.
Great week for Accolade, Inc. (NASDAQ:ACCD) institutional investors after losing 74% over the previous year
To get a sense of who is truly in control of Accolade, Inc. ( NASDAQ:ACCD ), it is important to understand the...
